Notes
Bosentan Use in Interstitial Lung Diseases.
International Study of Survival Outcomes in Idiopathic Pulmonary Fibrosis With Interferon Gamma Early Intervention.
References
European Biotechnology. Actelion. Tracleer clinician call review. New York: Lehman Brothers Equity Research 2005
European Biotechnology. Actelion. No change to numbers following R&D day. New York: Lehman Brothers Equity Research 2005
Rights and permissions
About this article
Cite this article
Tracleer Tackling Pulmonary Fibrosis. Pharmaceutical & Diagnostic Innovation 3, 8–12 (2005). https://doi.org/10.1007/BF03256992
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256992